Cryoablation Activates the cGAS–STING‐CXCL10 Axis in Macrophages to Enhance Anti‐Tumor Immunity in NSCLC
Advanced Science · 2026
DOI: 10.1002/advs.202521931 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Xinxin Zhi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Chemokine CXCL10, Cryosurgery, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Local ablative therapy has emerged as an essential treatment for patients with non‐small cell lung cancer (NSCLC). Whether cryoablation is superior to thermal ablation in the era of immunotherapy and the related mechanism remains undefined. We first observed superior progression‐free survival with cryoablation compared with thermal ablation in patients with oligoresidual disease after immunotherapy. Single‐cell RNA sequencing of human peripheral blood monocyte cells and mouse tumors showed that cryoablation combined with anti‐PD‐1 expanded more CXCL10 + macrophages than thermal ablation combination. CXCR3 blockade and inhibition of T cells egressing from draining lymph nodes abolished the systemic anti‐tumor efficacy. Mechanistically, tumor DNA released by cryoablation was taken up by macrophages, activating the cGAS–STING signaling pathway, increasing the pool of CXCL10 + macrophages and CXCL10 secretion. Our study demonstrated that CXCL10 + macrophages and the CXCR3 + T cells were critical mediators of the systemic anti‐tumor immunity induced by cryoablation in advanced NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Pathology and Frontier Innovation Center, School of Basic Medical Sciences, Fudan University, Shanghai, China.
- Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
ORCID-Profile: Shengxiang Ren
Förderung
- National Key Research and Development Program
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Zhi, X., Xing, Z., Luo, L., Wang, J., Liu, X., Yu, J., Yin, J., Chen, B., Liu, Y., Sun, H., Gao, G., Wang, L., Chen, X., Li, F., Ma, H., Wang, L., Yang, S., & Ren, S. (2026). Cryoablation Activates the cGAS–STING‐CXCL10 Axis in Macrophages to Enhance Anti‐Tumor Immunity in NSCLC. Advanced Science. https://doi.org/10.1002/advs.202521931
Vancouver
Zhi X, Xing Z, Luo L, Wang J, Liu X, Yu J, et al. Cryoablation Activates the cGAS–STING‐CXCL10 Axis in Macrophages to Enhance Anti‐Tumor Immunity in NSCLC. Advanced Science. 2026. doi:10.1002/advs.202521931
BibTeX
@article{Zhi2026,
author = {Zhi, Xinxin and Xing, Zhengcao and Luo, Libo and Wang, Jiale and Liu, Xinyu and Yu, Jia and Yin, Jizhong and Chen, Bin and Liu, Yiwei and Sun, Hui and Gao, Guanghui and Wang, Lei and Chen, Xiaoxia and Li, Fei and Ma, Hu and Wang, Lin and Yang, Shuo and Ren, Shengxiang},
title = {Cryoablation Activates the cGAS–STING‐CXCL10 Axis in Macrophages to Enhance Anti‐Tumor Immunity in NSCLC},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202521931}
}
EUVIMED